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Summary Statement 
Non-heme metallo oxygenases represent more than 80% of all known dioxygenases and a 
large number of monooxygenases, and thus a definition of the molecular basis of their catalytic 
action is highly relevant to many key biological processes. In this program we analyzed the 
involvement of non-heme iron in the catalytic pathway of the bacterial dioxygenase, 
protocatechuate-3,4-dioxygenase (PCD), and carried out comparative studies with the mamalian 
non-heme iron monooxygenase, liver phenylalanine hydroxylase (PAH), the mamalian coppper 
monooxygenase, dopamine-B-monooxygenase (DBM), and the bacterial non-heme iron 
monooxygenase, P. oleovorans epoxidase/hydroxylase (POEH). 
A protocol was developed to monitor ESO2 formation and decay under varying conditions 
of solvent and concentrations of reactants. The exceedingly high amounts of enzyme required for 
EXAFS is always a problem which must be overcome, but in this case the problem was 
confounded by the fact that a buildup of ESO2 of 2-3 mM would be required for accurate EXAFS 
analysis, which is far in excess of the total solubility of oxygen in water at room temperature. 
After many trials, procedures were worked out to buildup ESO2 under hyperbaric oxygen 
conditions (3-4 atm.) at 4DoUC, and to rapidly trap this species by freezing at -80 degrees. 
Kinetic methods were worked out to measure the germane rate constants and monitor formation 
and decomposition of the transients, in order to assure agreement with values previously 
determined by steady state and stopped flow analyses. Laborious, large-scale isolations were 
carried out to provide sufficient enzyme for these studies and for preparation of the sample which 
was actually subjected to EXAFS analysis. 
"ESO2" was trapped in an EXAFS cell at cryogenic temperature and its optical spectrum 
measured immediately prior to and following the EXAFS data collection by means of a specially 
constructed double beam fiber optic spectrometer. The spectra showed some alteration due to 
irradiation, which is plausibly assigned to ozinide formation in the 02-rich sample. Upon thawing 
and further reaction, the characteristic ES spectrum was observed. This confirms that, upon 
thawing, the expected turnover of "ESO2 " indeed occurred, thus depeleting oxygen and trapping 
the PCD as ES due to the prsence of excess substrate. Since the solution was frozen, care was 
taken to move the sample slightly during data collection to reduce or remove Bragg peak scattering. 
Preliminary analyses showed the following: (1) loss of chelation by substrate or product, (2) a six-
coordinate iron, similar to ES but in contrast to native PCD, (3) strong disorder of the first-shell 
relative to E or ES, (4) retention of histidyl ligation. First-shell analyses on E, ES, EI, and 
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complexes with transition state analog is complete. The iron in native PCD and its complexes with 
3-chloro-hydroxybenzoate (I) or TSA (TSA = 2-hydoxyisoniciotinic acid N-oxide) is five 
coordinate; in contrast, the iron in ES (S = protocatechuate, 5-bromoprotocatechuate, or 
dihydroxyphenylpropionate) is six coordinate. Average first-shell distances in E, ES, and EI are 
about 2.00 A, while E.TSA complexes possess average distances of 2.05 A. Excepting the 
anomalous EI complex, all species show two histidyl ligands at the active site. 
Other experiments in this phase of the program included preparation of crystals of PCD for 
solid state EXAFS measurements as a prelude to experiments were S and/or I will be diffused 
directly into such crystals. Also, careful reconstitution experiments on transferrin species were 
carried out in order to resolve some inconsistencies in our initial EXAFS reults with this protein. 
Very good progress was made in the preparation and characterization of modified 
phenylalanines and pterins. Alternate catalytic competencies for PAH were investigated using our 
novel substrate analogs, vinyl-Phe and pMeS-Phe.. A prototype of another novel class of 
compounds was prepared as a potential mechanism-based inhibitor for PAH. The p-pyridine 
analog of Phe has been prepared and characterized. If PAH is capable of oxygenating such 
compounds to the corresponding pyridine N-oxides, these should be potent ligands for the Fe and 
may be excellent inhibitors. Moreover, the N-oxides are very useful EXAFS probes in 
investigating the question of whether the Fe is actually participating in substrate oxygenation. 
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